Jump to main content
eTG Complete
Index
Search
Home
Rheumatology
Systemic vasculitides
Giant cell arteritis
Rheumatology
Assessment and initial management of musculoskeletal symptoms
Practical information on drugs used for musculoskeletal and rheumatological conditions
Adult-onset Still disease
Antiphospholipid syndrome
Autoinflammatory periodic fever syndromes
Back pain
Behçet syndrome
Crystal diseases including gout
Fibromyalgia
Idiopathic inflammatory myopathies
Immunoglobulin G
4
-related disease
Inflammatory connective tissue diseases
Juvenile idiopathic arthritis
Overview of limb conditions
Upper limb conditions
Lower limb conditions
Neck pain
Osteoarthritis
Musculoskeletal conditions in children and adolescents
Polymyalgia rheumatica
Pregnancy-related low back pain and pelvic pain
Raynaud phenomenon
Rheumatoid arthritis
Spondyloarthritis
Systemic vasculitides
Overview of systemic vasculitides
Giant cell arteritis
Overview of giant cell arteritis
Diagnosis of giant cell arteritis
Management overview for giant cell arteritis
Systemic corticosteroids for giant cell arteritis
Intensive induction therapy for giant cell arteritis
Immunomodulatory drugs for maintaining remission in giant cell arteritis
Follow-up for people with giant cell arteritis
References
Takayasu arteritis
Kawasaki disease
Polyarteritis nodosa
ANCA-associated vasculitides
Immunoglobulin A vasculitis
Cryoglobulinaemia and cryoglobulinaemic vasculitis
Transition of adolescents to adult rheumatology management
Viral arthritis
Giant cell arteritis
Published
December 2024
Overview of giant cell arteritis
Diagnosis of giant cell arteritis
Management overview for giant cell arteritis
Systemic corticosteroids for giant cell arteritis
Intensive induction therapy for giant cell arteritis
Immunomodulatory drugs for maintaining remission in giant cell arteritis
Follow-up for people with giant cell arteritis
